Abstract Submission

The American College of Rheumatology and Association of Rheumatology Professionals invite you to submit an abstract to ACR Convergence and take advantage of the opportunity to have your work peer reviewed by experts in the field.

View 2020 abstracts at acrabstracts.org or download the 2020 Abstract Supplement.

Abstract Submission Eligibility

Persons Eligible to Submit
Members and non-members of the ACR and ARP are eligible to submit an abstract.

Abstracts Eligible for Submission

  • Truly late-breaking, high-impact scientific research for which results were not available at the time of the abstract submission deadline (coming soon).
  • Late-breaking abstracts describing clinical trials or original and groundbreaking basic science may be submitted.
  • Important: Abstracts that do not meet these criteria will not be reviewed.

Abstracts Not Eligible for Submission

  • Abstracts submitted in the general abstract submission but not accepted should not be submitted to the late-breaking category.
  • An abstract is ineligible for consideration if it reports work that has been accepted for publication as a manuscript (e.g., full-length article, brief report, case report, concise communication or letter to the editor, etc.) prior to the late-breaking submission deadline (coming soon).
  • An abstract is ineligible for consideration if preliminary data were available at the time of the general abstract submission deadline (coming soon).
  • Multiple abstracts may not be submitted for one study unless substantially different research questions are being addressed in each abstract.
  • Case reports are not considered appropriate and will not be reviewed.

Abstract Submission Guidelines

Call for Abstracts Guidelines for Submission coming soon.

ACR Abstracts
The ACR seeks abstracts on the following topics:

  • Clinical practice of rheumatology
  • Teaching of rheumatology
  • Basic and translational science that contributes to the understanding of disease pathogenesis
  • Mechanisms and efficacy of therapeutics
  • Delivery of healthcare to patients with musculoskeletal and rheumatic disease

Abstract Submission Timeline

2021 abstract submission timeline coming soon.

Abstract Withdrawal

After the abstract submission period closes, presenting authors may submit a request to have an abstract withdrawn.

Withdrawal requests must be submitted by the presenting author by email to withdrawn@rheumatology.org and include the following:

  • Abstract ID number
  • Abstract title
  • Presenting author’s name

Removal of a withdrawn abstract from the online supplement of Arthritis & Rheumatology cannot be guaranteed if the request was received after (date to be announced).

Withdrawal or rejection of an abstract will not result in the refund of a submission fee. All submission fees are non-refundable.